Clincosm LogoSign in Get a demo

Asthma

Showing NaN - NaN of 192
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asthma Trial in Worldwide (Experimental: Tezepelumab, Placebo)

Completed
Has Results
  • Asthma
  • Experimental: Tezepelumab
  • Placebo
  • Dothan, Alabama
  • +288 more
Oct 29, 2021

Asthma Trial in Worldwide (Beclomethasone dipropionate, Placebo, Albuterol/salbutamol)

Completed
Has Results
  • Asthma
  • Beclomethasone dipropionate
  • +2 more
  • Costa Mesa, California
  • +130 more
Nov 5, 2021

Asthma, Elevated Blood Eosinophils, Oral Corticosteroid Dependence Trial in Worldwide (Reslizumab, Placebo, Non-Oral

Completed
Has Results
  • Asthma
  • +2 more
  • Bakersfield, California
  • +126 more
Nov 5, 2021

Asthma Trial in Worldwide (Reslizumab, Placebo)

Completed
Has Results
  • Asthma
  • Birmingham, Alabama
  • +225 more
Nov 5, 2021

Asthma Trial in Worldwide (Benralizumab (Medi-563), Placebo)

Completed
Has Results
  • Asthma
  • Benralizumab (Medi-563)
  • Placebo
  • Birmingham, Alabama
  • +212 more
Oct 20, 2021

Asthma Trial in Worldwide (Placebo once daily, QAW039 150 mg once daily, QAW039 450 mg once daily)

Terminated
Has Results
  • Asthma
  • Placebo once daily
  • +2 more
  • Newport Beach, California
  • +120 more
Oct 7, 2021

Asthma Trial in Worldwide (LOU064 100 mg, Placebo)

Terminated
Has Results
  • Asthma
  • LOU064 100 mg
  • Placebo
  • Denver, Colorado
  • +18 more
Oct 7, 2021

Asthma Trial in Worldwide (CJM112, Placebo to CJM112)

Completed
Has Results
  • Asthma
  • Fullerton, California
  • +28 more
Oct 7, 2021

Asthma Trial in Worldwide (QVM149, Salmeterol/fluticasone plus tiotropium)

Completed
Has Results
  • Asthma
  • QVM149
  • Salmeterol/fluticasone plus tiotropium
  • Berazategui, Buenos Aires, Argentina
  • +162 more
Oct 7, 2021

Asthma Trial in Worldwide (QAW039, Placebo)

Completed
Has Results
  • Asthma
  • Andalusia, Alabama
  • +141 more
Oct 6, 2021

Asthma Trial in Worldwide (QAW039, Placebo)

Completed
Has Results
  • Asthma
  • Flagstaff, Arizona
  • +109 more
Oct 6, 2021

Asthma Trial in Worldwide (QVM149 150/50/80 µg o.d., QVM149 150/50/160 µg o.d., salmeterol/fluticasone FDC 50/500 µg b.i.d.)

Completed
Has Results
  • Asthma
  • QVM149 150/50/80 μg o.d.
  • +2 more
  • Sofia, Bulgaria
  • +11 more
Sep 30, 2021

Asthma Trial in Worldwide (GB001, Placebo)

Completed
Has Results
  • Asthma
  • Birmingham, Alabama
  • +116 more
Aug 20, 2021

Asthma Trial in Berlin (AZD8154 nebuliser, AZD8154 Monodose DPI presented in capsules, AZD8154 Placebo Monodose DPI presented in

Terminated
  • Asthma
  • AZD8154 nebuliser
  • +2 more
  • Berlin, Germany
    Research Site
Aug 23, 2021

Asthma Trial in Worldwide (Benralizumab)

Completed
Has Results
  • Asthma
  • Benralizumab
  • Scottsboro, Alabama
  • +177 more
Mar 18, 2021

Asthma Trial in Worldwide (RELVAR/BREO, Salbutamol, Smart phone app)

Completed
Has Results
  • Asthma
  • Aventura, Florida
  • +65 more
Mar 17, 2021

Asthma Trial in Worldwide (CHF 5259 12.5 µg, CHF 5259 )

Completed
  • Asthma
  • CHF 5259 12.5 µg
  • CHF 5259 placebo
  • Ruse, Bulgaria
  • +27 more
Apr 6, 2021

Asthma Trial in Worldwide (CHF 5993 200/6/12.5 µg, CHF 1535 200/6 µg, CHF 1535 200/6 µg + Tiotropium Respimat 2.5 µg)

Completed
  • Asthma
  • CHF 5993 200/6/12.5 µg
  • +2 more
  • Caba, Argentina
  • +243 more
Apr 6, 2021

Asthma Trial in Worldwide (CHF 5259 plus Foster 100/6 µg, Foster 100/6 µg)

Completed
  • Asthma
  • CHF 5259 plus Foster 100/6 µg
  • Foster 100/6 µg
  • Dupnitza, Bulgaria
  • +43 more
Apr 6, 2021

Asthma Trial in Worldwide (FF/UMEC/VI (100/31.25/25) mcg, FF/UMEC/VI (100/62.5/25) mcg, FF/UMEC/VI (200/31.25/25) mcg)

Completed
Has Results
  • Asthma
  • FF/UMEC/VI (100/31.25/25) mcg
  • +10 more
  • Birmingham, Alabama
  • +408 more
Feb 26, 2021

Asthma Trial in Germany, United Kingdom (IPI-145, a PI3K Inhibitor, Placebo to match IPI-145)

Completed
  • Asthma
  • IPI-145, a PI3K Inhibitor
  • Placebo to match IPI-145
  • Berlin, Germany
  • +3 more
Mar 15, 2021

Asthma Trial in Germany, United Kingdom (GSK3511294, Placebo, Salbutamol/albuterol)

Completed
Has Results
  • Asthma
  • Hannover, Niedersachsen, Germany
  • +4 more
Feb 5, 2021

Asthma Trial in Germany, Netherlands, United Kingdom (Treatment A: Matching (morning dose) and QVM149 150/50/80 µg (evening

Completed
Has Results
  • Asthma
  • Treatment A: Matching placebo (morning dose) and QVM149 150/50/80 μg (evening dose)
  • +2 more
  • Berlin, Germany
  • +6 more
Dec 9, 2020

Asthma Trial in Worldwide (QAX576, Placebo)

Completed
  • Asthma
  • QAX576
  • Placebo
  • Phoenix, Arizona
  • +51 more
Dec 11, 2020

Asthma Trial in Germany, Russian Federation, United States (QAV680, QAV680 Placebo)

Terminated
  • Asthma
  • Cypress, California
  • +6 more
Dec 11, 2020